Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
Public ClinicalTrials.gov record NCT02945800. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Study of Nab-Paclitaxel in Combination With Gemcitabine for Treatment of Recurrent/Refractory Sarcoma in Teenagers and Young Adults
Study identification
- NCT ID
- NCT02945800
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Other
- Enrollment
- 59 participants
Conditions and interventions
Interventions
- Gemcitabine Drug
- nab-Paclitaxel Drug
Drug
Eligibility (public fields only)
- Age range
- 3 Years to 30 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 24, 2016
- Primary completion
- Nov 18, 2024
- Completion
- Feb 16, 2025
- Last update posted
- Apr 1, 2026
2016 – 2025
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham Comprehensive Cancer Center | Birmingham | Alabama | 35294 | — |
| Children's Hospital Los Angeles | Los Angeles | California | 90027 | — |
| Connecticut Children's Medical Center | Hartford | Connecticut | 06103 | — |
| A.I. duPont Hospital for Children, Delaware - Nemours | Wilmington | Delaware | 19603 | — |
| Shand's Hospital for Children at the University of Florida | Gainesville | Florida | 32608 | — |
| Nemours Children's Clinic | Jacksonville | Florida | 32207 | — |
| Holtz Children's Hospital at the University of Miami | Miami | Florida | 33136 | — |
| H. Lee Moffitt Cancer Center and Research Institute, Coordinating Center | Tampa | Florida | 33612 | — |
| University of Kentucky | Lexington | Kentucky | 40506 | — |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Baltimore | Maryland | 21231 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| Carolinas Medical Center, Levine Cancer Institute | Charlotte | North Carolina | 28303 | — |
| Nationwide Children's Hospital | Columbus | Ohio | 43205 | — |
| Vanderbilt - Ingram Cancer Center | Nashville | Tennessee | 37232 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02945800, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 1, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02945800 live on ClinicalTrials.gov.